Nasoaldo (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Nasoaldo, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal and perennial allergic rhinitis, and nasal polyps in adults and children as directed by a healthcare professional and is indicated for patients requiring local anti‑inflammatory therapy.

GNH USA supplies Nasoaldo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions.

Mometasone Furoate nasal spray is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching and sneezing. Seasonal allergic rhinitis: controls symptoms triggered by seasonal allergens. Perennial allergic rhinitis: provides year‑round relief of nasal inflammation. Nasal polyps: helps shrink polyps and improve nasal airflow.

Nasoaldo may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Sore throat. - Cough. - Altered taste perception.

Serious or Rare Side Effects: - Fungal infection of the nasal mucosa. - Severe or persistent nosebleeds. - Vision changes such as blurred vision or cataract formation. - Adrenal suppression with prolonged high‑dose use. - Anaphylactic or severe allergic reactions.

Before using Nasoaldo, consider the following safety measures.

Pregnancy: consult a healthcare provider; safety data are limited. Breastfeeding: discuss potential risks with a physician. Active infections: avoid use if a nasal or systemic infection is present. Long‑term therapy: do not discontinue abruptly; taper under medical supervision. Device sharing: do not share the nasal spray device with others. Store at below 25°C: keep in the original container, protect from moisture and heat.

Mometasone Furoate may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Nasal decongestant sprays used concurrently: risk of rebound congestion.

Moderate Interactions (Monitor Closely): - Antifungal azoles and macrolide antibiotics: may modestly increase plasma levels. - HIV protease inhibitors: potential for enhanced glucocorticoid activity.